Pharmacyclics Inc (NASDAQ:PCYC)
| 87.15 Real-Time Quote |  -1.11 / -1.26%Today’s Change | 41.37 Today|||52-Week Range 95.85 | +50.83% Year-to-Date |
Latest PCYC News | Press Releases
| Research Abstracts, Phase 2 Results, and Market Availability of Formulations and Trea... 8:22am / Benzinga | Acadia Pharmaceuticals Soars On Hedge Fund Investment Jun 10 / MotleyFool.com |
Today’s Trading
| Previous close | 88.26 |
| Today’s open | 88.52 |
| Day’s range | 86.90 - 88.72 |
| Volume | 46,800 |
| Average volume (3 months) | 739,950 |
| Market cap | $6.4B |
| Dividend yield | -- |
Data as of 11:00am ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +69.10% |
| Revenue growth (last year) | +895.87% |
| P/E ratio | 511.2 |
| Price/Sales | 45.78 |
| Price/Book | 46.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ONXXOnyx Pharmaceuticals... | -2.20 | -2.48% |
| RDYDr.Reddy's Laborator... | -0.43 | -1.17% |
| HSPHospira Inc | -0.20 | -0.53% |
| ELNElan Corporation PLC | -0.03 | -0.22% |
Data as of 11:05am ET, 06/19/2013
Financials
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $82.0M |
| Annual profit (last year) | $12.0M |
| Net profit margin | 14.62% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert W. Duggan |
Chief Operating Officer Mahkam Zanganeh, MD, MBA |
Corporate headquarters Sunnyvale, California |
Forecasts
